1357173-00-2

Upstream product

• 1357172-92-9 17-benzyl-3-methoxymorphinan-6-spiro-2'-(1',3'-dioxolane) 
• 1357172-90-7 3-methoxymorphinan-6-spiro-2'-(1',3'-dioxolane) 
• 1357172-85-0 3-methoxy-17-(2,2,2-trichloroethoxycarbonyl)morphinan-6-spiro-2'-(1',3'-dioxolane) 
• 1372779-45-7 17-cyclopropylmethyl-3-methoxymorphinan-6-spiro-2'-(1',3'-dioxolane) 
• 1043876-55-6 C₂₃H₃₁NO₄ 
• 1069111-48-3 17-cyclopropylmethyl-8,14-dehydro-3-methoxymorphinan-6-spiro-2'-(1',3'-dioxolane) 

Downstream Products

• 1357173-36-4 17-benzyl-6,7-didehydro-quinolino[2',3':6,7]morphinan-3-ol 
• 1357173-07-9 17-benzyl-6,7-didehydro-3-methoxy-quinolino[2',3':6,7]morphinan 

Relevant academic research and scientific papers

Synthesis of quinolinomorphinan-4-ol derivatives as δ opioid receptor agonists

The previously reported morphinan derivative SN-28 showed high selectivity and agonist activity for the δ opioid receptor. In the course of examining the structure-activity relationship of SN-28 derivatives, the derivatives with the 4-hydroxy group (SN-24